Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Non-Invasive Prenatal Testing (NIPT) Market


6. Market Share – Global Non-Invasive Prenatal Testing (NIPT) Market

6.1 By Method
6.2 By Technology
6.3 By Risk Type
6.4 By End User
6.5 By Region


7. Method – Global Non-Invasive Prenatal Testing (NIPT) Market

7.1 Ultrasound Detection
7.2 Biochemical Screening Tests
7.3 Cell-free DNA in Maternal Plasma Tests
7.4 Others


8. Technology – Global Non-Invasive Prenatal Testing (NIPT) Market

8.1 ELISA Kits (Enzyme-Linked Immunosorbent Assay Kits)
8.2 Next Generation Sequencing Systems
8.3 Microarray Analysis


9. Risk Type – Global Non-Invasive Prenatal Testing (NIPT) Market

9.1 High & Average Risk
9.2 Low Risk


10. End User – Global Non-Invasive Prenatal Testing (NIPT) Market

10.1 Specialty Clinics
10.2 Hospitals
10.3 Diagnostic Centers


11. Region – Global Non-Invasive Prenatal Testing (NIPT) Market

11.1 North America
11.2 Europe
11.3 Asia
11.4 Rest of the World (ROW)


12. Porters Five Forces

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes


13. Company Analysis

13.1 Eurofins Scientific

13.1.1 Overview
13.1.2 Recent Development & Strategies
13.1.3 Financial Insights

13.2 F. Hoffman-La Roche

13.2.1 Overview
13.2.2 Recent Development & Strategies
13.2.3 Financial Insights

13.3 Illumina

13.3.1 Overvie
13.3.2 Recent Development & Strategies
13.3.3 Financial Insights

13.4 Natera, Inc.

13.4.1 Overview
13.4.2 Recent Development & Strategies
13.4.3 Financial Insights

13.5 PerkinElmer Inc.

13.5.1 Overview
13.5.2 Recent Development & Strategies
13.5.3 Financial Insights

13.6 Quest Diagnostics

13.6.1 Overview
13.6.2 Recent Development & Strategies
13.6.3 Financial Insights

13.7 Thermo Fisher Scientific

13.7.1 Overview
13.7.2 Recent Development & Strategies
13.7.3 Financial Insights

13.8 Agilent Technologies

13.8.1 Overview
13.8.2 Recent Development & Strategies
13.8.3 Financial Insights



List of Figures

Figure-01: Global – Non-Invasive Prenatal Testing (NIPT) Market (Billion US$), 2018 – 2021
Figure-02: Global – Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Billion US$), 2022 – 2027
Figure-03: Method – Ultrasound Detection Market (Million US$), 2018 – 2021
Figure-04: Method – Forecast for Ultrasound Detection Market (Million US$), 2022 – 2027
Figure-05: Method – Biochemical Screening Tests Market (Million US$), 2018 – 2021
Figure-06: Method – Forecast for Biochemical Screening Tests Market (Million US$), 2022 – 2027
Figure-07: Method – Cell-free DNA in Maternal Plasma Tests Market (Million US$), 2018 – 2021
Figure-08: Method – Forecast for Cell-free DNA in Maternal Plasma Tests Market (Million US$), 2022 – 2027
Figure-09: Method – Others Market (Million US$), 2018 – 2021
Figure-10: Method – Forecast for Others Market (Million US$), 2022 – 2027
Figure-11: Technology – ELISA Kits (Enzyme-Linked Immunosorbent Assay Kits) Market (Million US$), 2018 – 2021
Figure-12: Technology – Forecast for ELISA Kits (Enzyme-Linked Immunosorbent Assay Kits) Market (Million US$), 2022 – 2027
Figure-13: Technology – Next Generation Sequencing Systems Market (Billion US$), 2018 – 2021
Figure-14: Technology – Forecast for Next Generation Sequencing Systems Market (Billion US$), 2022 – 2027
Figure-15: Technology – Microarray Analysis Market (Million US$), 2018 – 2021
Figure-16: Technology – Forecast for Microarray Analysis Market (Million US$), 2022 – 2027
Figure-17: Risk Type – High & Average Risk Market (Billion US$), 2018 – 2021
Figure-18: Risk Type – Forecast for High & Average Risk Market (Billion US$), 2022 – 2027
Figure-19: Risk Type – Low Risk Market (Million US$), 2018 – 2021
Figure-20: Risk Type – Forecast for Low Risk Market (Million US$), 2022 – 2027
Figure-21: End-User – Specialty Clinics Market (Million US$), 2018 – 2021
Figure-22: End-User – Forecast for Specialty Clinics Market (Million US$), 2022 – 2027
Figure-23: End-User – Hospitals Market (Million US$), 2018 – 2021
Figure-24: End-User – Forecast for Hospitals Market (Million US$), 2022 – 2027
Figure-25: End-User – Diagnostic Centers Market (Billion US$), 2018 – 2021
Figure-26: End-User – Forecast for Diagnostic Centers Market (Billion US$), 2022 – 2027
Figure-27: North America – Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 – 2021
Figure-28: North America – Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 – 2027
Figure-29: Europe – Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 – 2021
Figure-30: Europe – Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 – 2027
Figure-31: Asia – Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 – 2021
Figure-32: Asia – Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 – 2027
Figure-33: Rest of the World (RoW) – Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 – 2021
Figure-34: Rest of the World (RoW) – Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 – 2027
Figure-35: Eurofins Scientific – Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 – 2021
Figure-36: Eurofins Scientific – Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 – 2027
Figure-37: F. Hoffman-La Roche – Global Revenue (Billion US$), 2018 – 2021
Figure-38: F. Hoffman-La Roche – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-39: Illumina – Global Revenue (Billion US$), 2018 – 2021
Figure-40: Illumina – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-41: Natera, Inc. – Global Revenue (Billion US$), 2018 – 2021
Figure-42: Natera, Inc. – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-43: PerkinElmer Inc. – Global Revenue (Billion US$), 2018 – 2021
Figure-44: PerkinElmer Inc. – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-45: Quest Diagnostics – Global Revenue (Million US$), 2018 – 2021
Figure-46: Quest Diagnostics – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-47: Thermo Fisher Scientific – Global Revenue (Billion US$), 2018 – 2021
Figure-48: Thermo Fisher Scientific – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-49: Agilent Technologies – Global Revenue (Billion US$), 2018 – 2021
Figure-50: Agilent Technologies – Forecast for Global Revenue (Billion US$), 2022 – 2027

List of Tables

Table-01: Global – Non-Invasive Prenatal Testing (NIPT) Market Share by Method (Percent), 2018 – 2021
Table-02: Global – Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by Method (Percent), 2022 – 2027
Table-03: Global – Non-Invasive Prenatal Testing (NIPT) Market Share by Technology (Percent), 2018 – 2021
Table-04: Global – Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by Technology (Percent), 2022 – 2027
Table-05: Global – Non-Invasive Prenatal Testing (NIPT) Market Share by Risk Type (Percent), 2018 – 2021
Table-06: Global – Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by Risk Type (Percent), 2022 – 2027
Table-07: Global – Non-Invasive Prenatal Testing (NIPT) Market Share by End-User (Percent), 2018 – 2021
Table-08: Global – Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by End-User (Percent), 2022 – 2027
Table-09: Global – Non-Invasive Prenatal Testing (NIPT) Market Share by Region (Percent), 2018 – 2021
Table-10: Global – Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by Region (Percent), 2022 – 2027